Literature DB >> 29759737

Long-term outcome of cryopreserved allograft for aortic valve replacement.

Francesco Nappi1, Antonio Nenna2, Tommasangelo Petitti3, Cristiano Spadaccio4, Ivancarmine Gambardella5, Mario Lusini2, Massimo Chello2, Christophe Acar6.   

Abstract

OBJECTIVE: The most efficient surgical approach to severe aortic valve disease in the young adult is still debated: cryopreserved aortic allograft offers excellent hemodynamic and avoid anticoagulation, but long-term durability is influenced by structural valve deterioration (SVD). This study aimed to describe long-term results of aortic allografts and to identify factors influencing long-term durability.
METHODS: From January 1993 to August 2010, 210 patients underwent aortic allograft replacement via the free-hand subcoronary implantation technique (N = 55) or root replacement with coronary reimplantation (N = 155). Clinic and echocardiographic follow-up was updated to April 2016.
RESULTS: Overall mortality and cardiac mortality occurred in 80 (38.1%) and 64 (30.5%) patients, respectively. Reoperation was required in 69 cases (32.8%), whereas SVD required reoperation in 57 cases (27.1%). No early endocarditis occurred, whereas late endocarditis occurred in 4 patients. The free-hand technique seems to be associated with improved left ventricular remodeling compared with the root-replacement technique, and smaller allograft size represents a predictor of reoperation independently on the surgical technique used. In the overall population, there were 44 women of childbearing age, and 37 patients remained pregnant during the follow-up of the study. No differences were found in the clinical outcomes among women who had children and who did not.
CONCLUSIONS: Cryopreserved allograft is a valid option, especially in complex infective endocarditis and in women of childbearing age. A careful choice of allograft size and implantation technique can reduce the risk of SVD.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  allograft; aortic valve replacement; cryopreserved aortic allograft; endocarditis; long-term; structural valve degeneration

Mesh:

Year:  2018        PMID: 29759737     DOI: 10.1016/j.jtcvs.2018.04.040

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

Review 1.  The use of allogenic and autologous tissue to treat aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Mario Lusini; Antonio Nenna; Ivancarmine Gambardella; Massimo Chello
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.

Authors:  Emanuela S Fioretta; Sarah E Motta; Valentina Lintas; Sandra Loerakker; Kevin K Parker; Frank P T Baaijens; Volkmar Falk; Simon P Hoerstrup; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2020-09-09       Impact factor: 32.419

Review 3.  Sharing of decision-making for infective endocarditis surgery: a narrative review of clinical and ethical implications.

Authors:  Francesco Pollari; Cristiano Spadaccio; Michela Cuomo; Massimo Chello; Antonio Nenna; Theodor Fischlein; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

Review 4.  A management framework for left sided endocarditis: a narrative review.

Authors:  Francesco Nappi; Cristiano Spadaccio; Marc R Moon
Journal:  Ann Transl Med       Date:  2020-12

Review 5.  A narrative review of early surgery versus conventional treatment for infective endocarditis: do we have an answer?

Authors:  Umberto Benedetto; Cristiano Spadaccio; Federico Gentile; Marc R Moon; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

Review 6.  A narrative review of the interpretation of guidelines for the treatment of infective endocarditis.

Authors:  Umberto Benedetto; Sanjeet Singh Avtaar Singh; Cristiano Spadaccio; Marc R Moon; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

Review 7.  The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review.

Authors:  Francesco Nappi; Cristiano Spadaccio; Christos Mihos; Kasra Shaikhrezai; Christophe Acar; Marc R Moon
Journal:  Ann Transl Med       Date:  2020-12

Review 8.  The New Challenge for Heart Endocarditis: From Conventional Prosthesis to New Devices and Platforms for the Treatment of Structural Heart Disease.

Authors:  Francesco Nappi; Adelaide Iervolino; Sanjeet Singh Avtaar Singh
Journal:  Biomed Res Int       Date:  2021-06-14       Impact factor: 3.411

Review 9.  Trends in Managing Cardiac and Orthopaedic Device-Associated Infections by Using Therapeutic Biomaterials.

Authors:  Stefania Scialla; Giorgia Martuscelli; Francesco Nappi; Sanjeet Singh Avtaar Singh; Adelaide Iervolino; Domenico Larobina; Luigi Ambrosio; Maria Grazia Raucci
Journal:  Polymers (Basel)       Date:  2021-05-12       Impact factor: 4.329

Review 10.  Revisiting the guidelines and choice the ideal substitute for aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Cristiano Spadaccio; Christophe Acar
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.